====== Anticoagulation Resumption after intracranial hemorrhage ======

Only randomized controlled trials, either pragmatic or explanatory, can provide more conclusive answers for this important clinical question
((Hawkes MA, Rabinstein AA. Anticoagulation for atrial fibrillation after
intracranial hemorrhage: A systematic review. Neurol Clin Pract. 2018
Feb;8(1):48-57. doi: 10.1212/CPJ.0000000000000425. Review. PubMed PMID: 29517050;
PubMed Central PMCID: PMC5839688.
)).

In 2018, a systematic review and meta-analysis showed that resuming [[anticoagulant]] therapy after interruption for anticoagulation-associated [[intracranial hemorrhage]] reduced the risks of thromboembolic events, without significantly increasing the risks of ICH recurrence and long-term mortality
((Zhou Z, Yu J, Carcel C, Delcourt C, Shan J, Lindley RI, Neal B, Anderson CS,
Hackett ML. Resuming anticoagulants after anticoagulation-associated intracranial
haemorrhage: systematic review and meta-analysis. BMJ Open. 2018 May
14;8(5):e019672. doi: 10.1136/bmjopen-2017-019672. PubMed PMID: 29764874; PubMed 
Central PMCID: PMC5961574.
)). 

see [[Anticoagulation Resumption after chronic subdural hematoma]].

see [[Anticoagulation Resumption after intracerebral hemorrhage]].

see [[Anticoagulation Resumption after traumatic brain injury]].